Skip to main content
logo
Can-Fite BioPharma Ltd. (TLV:CANF)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
341.50
-4.80 (-1.39%)
Sep 10, 2026, 5:24 PM IDT

Can-Fite BioPharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-9.55-9.83-7.88-7.63-10.17-12.62
Depreciation & Amortization
00.020.010.020.010.01
Loss (Gain) From Sale of Investments
-000.01-0.010.23-0.16
Stock-Based Compensation
0.180.340.360.260.260.47
Other Operating Activities
-0.010.080.13-0.130.170.01
Change in Accounts Payable
-0.470.540.19-0.47-0.060.39
Change in Unearned Revenue
-0.41-0.41-0.35-0.74-0.811.4
Change in Other Net Operating Assets
0.750.3-0.110.27-0.430.64
Operating Cash Flow
-9.51-8.95-7.64-8.44-10.8-9.86
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0-0-0.01-0-0.01-0.01
Investment in Securities
-4-1.50.59.51-14.5
Investing Cash Flow
-4-01.50.59.5-14.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
10.049.647.229.14-21.76
Other Financing Activities
---0.51---1.31
Financing Cash Flow
10.049.646.719.14-20.46

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
00.01-0.020.1-0.110.03
Net Cash Flow
-3.470.70.551.3-1.41-3.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-9.51-8.95-7.64-8.44-10.81-9.87
Free Cash Flow Growth
------
Free Cash Flow Margin
-2348.89%-2210.12%-1133.83%-1136.20%-1334.57%-1156.98%
Free Cash Flow Per Share
-3.24-5.44-10.54-19.81-39.76-53.53
Levered Free Cash Flow
-5.42-4.99-4.82-5.12-6.51-5.98
Unlevered Free Cash Flow
-5.42-4.99-4.82-5.12-6.51-5.98

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.02
Change in Working Capital
-0.130.43-0.27-0.94-1.32.43